Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity
Background Doxorubicin and other anthracyclines are crucial cancer treatment drugs. However, they are associated with significant cardiotoxicity, severely affecting patient care and limiting dosage and usage. Previous studies have shown that low carbon monoxide (CO) concentrations protect against do...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2024-05-01
|
| Cyfres: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.ahajournals.org/doi/10.1161/JAHA.123.032067 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|